Literature DB >> 1865199

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

W R Gibb1, A J Lees.   

Abstract

In six control subjects pars compacta nerve cells in the ventrolateral substantia nigra had a lower melanin content than nerve cells in the dorsomedial region. This coincides with a natural anatomical division into ventral and dorsal tiers, which represent functionally distinct populations. In six cases of Parkinson's disease (PD) the ventral tier showed very few surviving nerve cells compared with preservation of cells in the dorsal tier. In 13 subjects without PD, but with nigral Lewy bodies and cell loss, the degenerative process started in the ventral tier, and spread to the dorsal tier. This pattern of selective degeneration of nigrostriatal neurons is not seen in ageing or after acute administration of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865199      PMCID: PMC488535          DOI: 10.1136/jnnp.54.5.388

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  33 in total

1.  Aging and extrapyramidal function.

Authors:  P L McGeer; E G McGeer; J S Suzuki
Journal:  Arch Neurol       Date:  1977-01

2.  STRIATO-NIGRAL DEGENERATION.

Authors:  R D ADAMS; L VANBOGAERT; H VANDEREECKEN
Journal:  J Neuropathol Exp Neurol       Date:  1964-10       Impact factor: 3.685

3.  The brain-stem lesions in Parkinsonism.

Authors:  J G GREENFIELD; F D BOSANQUET
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-11       Impact factor: 10.154

4.  Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum.

Authors:  L F Langer; A M Graybiel
Journal:  Brain Res       Date:  1989-10-02       Impact factor: 3.252

5.  Cell clusters in the nucleus accumbens of the rat, and the mosaic relationship of opiate receptors, acetylcholinesterase and subcortical afferent terminations.

Authors:  M Herkenham; S M Edley; J Stuart
Journal:  Neuroscience       Date:  1984-03       Impact factor: 3.590

6.  Organization of the ascending striatal afferents in monkeys.

Authors:  J Szabo
Journal:  J Comp Neurol       Date:  1980-01-15       Impact factor: 3.215

7.  Striatonigral degeneration. A clinicopathological study.

Authors:  J M Fearnley; A J Lees
Journal:  Brain       Date:  1990-12       Impact factor: 13.501

8.  Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum.

Authors:  J H Fallon; R Y Moore
Journal:  J Comp Neurol       Date:  1978-08-01       Impact factor: 3.215

9.  Possible role of neuromelanin in the pathogenesis of Parkinson's disease.

Authors:  D M Mann; P O Yates
Journal:  Mech Ageing Dev       Date:  1983-02       Impact factor: 5.432

10.  Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases.

Authors:  E G Spokes; R Bannister; D R Oppenheimer
Journal:  J Neurol Sci       Date:  1979-09       Impact factor: 3.181

View more
  126 in total

1.  Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.

Authors:  S J Cragg; S A Greenfield
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

Review 2.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

3.  Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.

Authors:  Jian-Hui Zhu; Scott M Kulich; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.

Authors:  T Uchihara; H Kondo; K Kosaka; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Neuronal selectivity of ATP-sensitive potassium channels in guinea-pig substantia nigra revealed by responses to anoxia.

Authors:  K P Murphy; S A Greenfield
Journal:  J Physiol       Date:  1992       Impact factor: 5.182

Review 6.  Neuroprotection in Parkinson's disease: an elusive goal.

Authors:  William C Koller; Maria G Cersosimo
Journal:  Curr Neurol Neurosci Rep       Date:  2004-07       Impact factor: 5.081

7.  A neurocomputational account of cognitive deficits in Parkinson's disease.

Authors:  Sébastien Hélie; Erick J Paul; F Gregory Ashby
Journal:  Neuropsychologia       Date:  2012-06-08       Impact factor: 3.139

8.  Amygdala pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; R A de Vos; E N Jansen; J Bohl; K Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 9.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

10.  Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.

Authors:  Antonio Martín-Bastida; Nicholas P Lao-Kaim; Andreas Antonios Roussakis; Graham E Searle; Yue Xing; Roger N Gunn; Stefan T Schwarz; Roger A Barker; Dorothee P Auer; Paola Piccini
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.